HomeCOHANCE • NSE
add
Cohance Lifesciences Ltd
Previous close
₹535.45
Day range
₹534.60 - ₹542.50
Year range
₹518.15 - ₹1,121.15
Market cap
205.02B INR
Avg Volume
840.58K
P/E ratio
66.39
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.56B | 115.57% |
Operating expense | 3.38B | 184.55% |
Net income | 740.80M | -9.89% |
Net profit margin | 13.33 | -58.21% |
Earnings per share | 1.93 | — |
EBITDA | 1.23B | 19.85% |
Effective tax rate | 20.75% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.00B | -38.94% |
Total assets | 55.68B | 122.25% |
Total liabilities | 16.44B | 244.53% |
Total equity | 39.25B | — |
Shares outstanding | 381.86M | — |
Price to book | 5.40 | — |
Return on assets | — | — |
Return on capital | 5.92% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 740.80M | -9.89% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
1,212
